Schott K, Jenner A, Wiethölter H, Schabet M, Stevens A
University Neurology Clinic, Laboratory of Neuroimmunology, Tübingen, F.R.G.
J Neuroimmunol. 1988 Nov;20(1):53-61. doi: 10.1016/0165-5728(88)90114-2.
Acute experimental allergic neuritis (EAN) of Lewis rats was monitored by clinical and electrophysiological tests for 60 days. Sciatic nerve myelin proteins were analyzed by quantitative microgel electrophoresis and electroimmunoblotting at different clinical stages of the disease. The clinical severity of EAN and the demyelination as measured by electrophysiological tests and myelin protein concentrations in sciatic nerve did not correspond during the course of the disease. Demyelination reached its peak after partial clinical recovery and was still present on day 60. The major peripheral nervous system (PNS) myelin proteins P0, P1 and P2 decreased at different rates during the course of the disease, indicating possible differences in their proteolytic degradation. Treatment with Freund's complete adjuvant (CFA) alone resulted in alterations of membrane and myelin protein patterns challenging the widely held belief that pure CFA is inert with regard to demyelination.
通过临床和电生理测试对Lewis大鼠的急性实验性过敏性神经炎(EAN)进行了60天的监测。在疾病的不同临床阶段,通过定量微凝胶电泳和电免疫印迹分析坐骨神经髓磷脂蛋白。在疾病过程中,EAN的临床严重程度与通过电生理测试和坐骨神经髓磷脂蛋白浓度测量的脱髓鞘情况并不相符。脱髓鞘在部分临床恢复后达到峰值,并且在第60天时仍然存在。主要的外周神经系统(PNS)髓磷脂蛋白P0、P1和P2在疾病过程中以不同速率下降,表明它们的蛋白水解降解可能存在差异。单独使用弗氏完全佐剂(CFA)治疗导致膜和髓磷脂蛋白模式发生改变,这对广泛持有的纯CFA在脱髓鞘方面无活性的观点提出了挑战。